An Introduction to Flow Cytometry

por Camplejohn, R.S.
Publicado 1992

Guide to Flow Cytometry Methods

por Camplejohn, R.S.
Publicado 1992

Proceedings: Immunological mechanisms in control of malignant disease.

por Bone, C., Camplejohn, R. S.
Publicado 1974

In vitro labelling of childhood cancers with tritiated thymidine.

por Camplejohn, R. S., Aherne, W. A.
Publicado 1974

Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

por Walker, R. A., Camplejohn, R. S.
Publicado 1988

In vivo cell synchrony in the L1210 mouse leukaemia studied with 5-fluorouracil or 5-fluorouracil followed by cold thymidine infusion.

por Camplejohn, R. S., Schultze, B., Maurer, W.
Publicado 1977

The flow cytometry of melanocytic skin lesions.

por Newton, J. A., Camplejohn, R. S., McGibbon, D. H.
Publicado 1988

Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins

por Camplejohn, R S, Hodgson, S, Carter, N, Kato, B S, Spector, T D
Publicado 2006

Management of Breast Cancer in BRCA1/2 Mutation Carriers

por Eeles, R. A., Camplejohn, R., Peacock, J., McMillan, T.
Publicado 1999

Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer.

por Masters, J. R., Camplejohn, R. S., Millis, R. R., Rubens, R. D.
Publicado 1987

Assessment of inherent fluctuations of mitotic and labelling indices of human tumours.

por Aherne, W. A., Camplejohn, R. S., Al-Wiswasy, M., Ford, D., Kellerer, A. M.
Publicado 1977

Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.

por Camplejohn, R. S., Brock, A., Barnes, D. M., Gillett, C., Raikundalia, B., Kreipe, H., Parwaresch, M. R.
Publicado 1993

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer.

por O'Reilly, S. M., Barnes, D. M., Camplejohn, R. S., Bartkova, J., Gregory, W. M., Richards, M. A.
Publicado 1991

Radiation-induced G(1) arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations

por Boyle, J M, Greaves, M J, Camplejohn, R S, Birch, J M, Roberts, S A, Varley, J M
Publicado 1999

DNA index, S-phase fraction, histological grade and prognosis in breast cancer.

por O'Reilly, S. M., Camplejohn, R. S., Barnes, D. M., Millis, R. R., Allen, D., Rubens, R. D., Richards, M. A.
Publicado 1990

A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage.

por Camplejohn, R. S., Perry, P., Hodgson, S. V., Turner, G., Williams, A., Upton, C., MacGeoch, C., Mohammed, S., Barnes, D. M.
Publicado 1995

An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model.

por Thomas, H., Hanby, A. M., Smith, R. A., Hagger, P., Patel, K., Raikundalia, B., Camplejohn, R. S., Balkwill, F. R.
Publicado 1996

Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study.

por Kalra, R., Wade, K. E., Hands, L., Styles, P., Camplejohn, R., Greenall, M., Adams, G. E., Harris, A. L., Radda, G. K.
Publicado 1993

The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.

por Camplejohn, R. S., Ash, C. M., Gillett, C. E., Raikundalia, B., Barnes, D. M., Gregory, W. M., Richards, M. A., Millis, R. R.
Publicado 1995

Differential expression of the topoisomerase II alpha and beta genes in human breast cancers.

por Sandri, M. I., Hochhauser, D., Ayton, P., Camplejohn, R. C., Whitehouse, R., Turley, H., Gatter, K., Hickson, I. D., Harris, A. L.
Publicado 1996